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license (http://creativecommons.org/Summary Magnesium (Mg) or its alloys have shown great potential as promising biocorrosive
or biodegradable implantation materials and/or internal fixators, owing to their good biocom-
patibility and osteoinductive potential. However, poor anticorrosion property or rapid biodeg-
radation has limited their clinical applications where initial mechanical stabilisation is
required. One of the practical approaches for decreasing its biodegradation is to introduce a
coating on Mg or its alloys. The current study compared the two most widely used coating
techniques, i.e., microarc oxidation (MAO) and electrophoresis deposition (EPD), for coating
onto the MgeZr pin surface, both in vitro and in vivo, to determine which method can prevent
MgeZr alloy degradation better. In vitro pH measurement and in vivo microcomputed tomo-
graphic evaluation were used for determining its degradation rate. Our in vitro and in vivo
testing results indicated that EPD demonstrated better corrosion resistance than MAO,
implying the potential of electrochemical technology for surface modification of Mg or its
alloys developed for orthopaedic applications.
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niques developed for enhancing degradation resistance ofMagnesium (Mg) and its alloys have high electronegative po-
tentials and can, therefore, degrade in an aqueous environ-
ment via an electrochemical reaction, which produces Mg
hydroxide and hydrogen gas [1,2]. Especially in physiological
conditions where a high chloride concentration exists, Mg al-
loys present a faster degradation rate because Mg hydroxide
can rapidly convert into highly solubleMg chloride [3]. AsMgor
its alloys possess a Young’s modulus closer to bone
(EZ 3e20 GPa), it is logical to conclude that Mg and its alloys
have great potential to become desirable biodegradable or
biocorrosive materials of medical implants for clinical appli-
cations, such as orthopaedic implants and cardiovascular
stents [4e6]. In recent years, much endeavour has beenmade
to develop appropriate biodegradable implants of Mg-based
alloys for bone fracture fixation at the initial stage and then
gradually degrade with healing towards an accelerated frac-
ture repair. Yet, rapid degradation of Mg and its alloys in vivo
may affect mechanical integrity of the healing complex
[7e13]. Controlling Mg or its alloys’ degradation rates in vivo
remains a technical or conceptual obstacle to overcome prior
to their clinical validation and applications. Although alloying
elements and processing technology may decrease the
degradation rate significantly, surface coating still remains an
effective way to increase degradation resistance of Mg or its
alloys [14e16].
Microarc oxidation (MAO), also known as plasma elec-
trolytic oxidation, has been a commonly used industrial
technology for metal surface coating. Briefly, application of
high voltages (exceeding the dielectric breakdown voltage
of the oxide) is involved in the treatment of metals in an
alkaline electrolyte, leading to the formation of electric
discharges/sparks locally. The plasma induced by local high
temperature will contribute to reactions between metal
substrate and ingredients in electrolytes. Therefore,
ceramic coatings with higher corrosion and wear resistance
will be adhered to the substrate tightly [17]. Basically,
properties of coatings depend on electrolytic parameters
and composition of electrolytes [17]. Many researches
focused on the use of MAO in biological applications to
decrease degradation rates of Mg or its alloys in vivo
[18,19]. Generally, anodised layers can protect substrates
from corrosion efficiently in the initial immersion stage.
However, during implantation, media can still penetrate
into the substrate through the channels connected by mi-
cropores, subsequently accelerating degradation of the
substrate [20]. Thus, optimisation of electrolytic parame-
ters and alteration of electrolyte ingredients have become
the major factors affecting the potential of MAO technology
in medical applications. Apart from the MAO method,
electrophoresis deposition (EPD) is also a widely used
anodised process [21]. As no evaporated gas is involved in
EPD, pores can be avoided during the coating process. The
current study was designed to compare MAO and EPD, the
available surface coating techniques for protection of Mg or
its alloys against corrosion, as no efforts had so far been
made to explore their potential application in controlling
degradation rates of Mg or its alloys in vivo. The method-
ological approaches for evaluation and findings of the cur-
rent study may lay down a foundation to understand theapplication potential of relevant surface-coating tech-




MgeZr (MagnesiumeZirconium) alloy (nominal concentra-
tion: 0.8 wt% Zr) pins, with a diameter of 0.5 mm, were
prepared according to relevant previous publications [22].
Commercially pure Mg (99.9%) and highly pure Zr powder
(99.9%) were melted and cast under a mixed atmosphere of
sulfur hexafluoride (SF6) and carbon dioxide (CO2). The as-
cast binary magnesium alloy was further cut into rods of
diameter 0.5 mm. The surface of MgeZr alloy was polished
using an abrasive paper of 500e1000 mesh and then washed
ultrasonically with acetone and deionised water for three
times.
Preparation of MAO specimens
Surface coatings of MgeZr pins were fabricated using the
MAO process [21]. The electrolytic solution was composed
of sodium silicate (5 g/L), potassium fluoride (8 g/L), and
potassium hydroxide (11 g/L). The key fabrication param-
eters were as follows: voltage 600 V, frequency 600 Hz, and
treatment time 10 min.
Preparation of EPD specimens
The EPD solution included three reagents with a ratio of
electrophoretic paint (Datong chemistry Co., Ltd, Dongy-
ing, China):solvent (Datong Chemistry Co., Ltd):pure
water Z 1:1:10; the parameters of electrophoresis were
set as voltage 150e160 V and treatment time 75e80 s.
In vitro pH tests of immersion process
MgeZr pins undergoing EPD and MAO processes were cut
into 1 cm long pieces, and then washed ultrasonically with
acetone and distilled water for three times. Each surface-
coating group included three samples, and all the samples
were immersed in 5 mL Dulbecco’s Modified Eagle Medium
(DMEM, Gibco, Invitrogen, Califorlia, USA) based on the
requirement of minimum solution volume-to-specimen area
according to the standard of American Society of Testing
Materials (ASTM)-G31-72 [23]. In an incubator (MCO-20AIC,
Sanyo, Osaka, Japan) at 37 C and 5% CO2, pH values of
media were measured with a pH meter (S209, Mettler
Toledo, Columbus, Ohio, USA) at various time points over a
period of 11 days.
In vivo degradation
Sterilised pins were inserted into surgically predrilled
bone tunnels from the distal femur of 3-month-old male
mice obtained in animal house of the Chinese University of
Surface coating of magnesium alloy 43Hong Kong. Animal ethics approval was obtained from the
Chinese University of Hong Kong (Ref. No. 10/049/MIS).
Mice were divided randomly into MAO and EPD groups
(nZ 4 for each group). Animal surgery for implantation was
conducted according to the previously described protocol
[9,24]. The mice were anaesthetised with a combination of
ketamine (75 mg/kg) and xylazine (10 mg/kg) through
intraperitoneal injection. Then, an incision was made on
the skin of the distal femur for exposure of the left knee
under general anaesthesia. Osseous tunnel was predrilled
along the axis of the bone shaft from the middle point of
femoral condyles. Pins (0.5 mm in diameter and 5 mm in
length) were then inserted into the bone tunnel through the
hole made at the distal femur prior to closing the wound
with a suture. The mice were observed closely for 48 h
immediately after surgery in the animal house. A general
inspection of the operated distal femur was made weekly
for 4 weeks postoperatively by observing the radiographs
taken by a digital X-ray machine (Faxitron MX-20, Faxitron
Bioptics, Tucson, Arizona, USA) operating at 30 keV for 10 s.
An in vivomicrocomputed tomograph (micro-CT; Viva CT40,
Scanco Medical AG, Bru¨ttisellen, Switzerland) with a voxel
size of 20 mm was used to monitor degradation behaviour of
pins at Week 1, Week 2, Week 3, and Week 4 post-
operatively. Basically, a three-dimensional volume of in-
terest of the implanted pins was reconstructed with an
appropriate threshold value (i.e., 125) to evaluate density
changes of pins [using hydroxyapatite (HA) as the refer-
ence] in both groups.
Statistical analysis
SPSS version 16.0 (IBM, Armonk, New York, USA) was used
for statistical analysis. Differences between groups were
analysed using one-way analysis of variance (ANOVA), fol-
lowed by post hoc Tukey’s test. A p value of <0.05 was
considered statistically significant.
Results
Micromorphology of coated pins
After MgeZr pins were coated using the MAO and EPD
methods, cross-sections of magnesium alloys were observed
with a scanning electron microscope (SEM; Fig. 1). Results
showed that both methods provided a protective layer on
the surface of magnesium alloys. In case of both coatings,
homogenous layers, approximately 6 mm in thickness, were
obtained.
In vitro immersion tests
Experimental results of immersion of magnesium alloys
in vitro are summarised in Fig. 2. The pH values of media
for both groups increased fast in the first 24 h, followed by
a gradual decrease. The highest mean pH value of MAO and
EPD specimens was 8.2 and 7.7, respectively, indicating
better protective effects of EPD coatings. In the later stage
of immersion, the gap between pH values remained nearly
constant (i.e., 0.5).In vivo experiments
X-rays
Radiographic images in Fig. 3 do not demonstrate any sign
of osteomyelitis of the operated femora postoperatively,
indicating excellent biocompatibility of both coated Mg
alloys. Hydrogen bubbles resulting from the degradation of
Mg could be observed only around the implanted tissue of
the MAO group within the initial 2 postoperative weeks.
Micro-CT analysis
After a MgeZr pin was implanted into the distal femur of
mice, the initial pin insertion and its placement were
confirmed by micro-CT immediately after implantation
surgery (Fig. 4). Recently, we established a monitoring
protocol to compare volume changes of the Mg alloy im-
plants to assess their corrosion rates in vivo [25]. However,
deposition of corrosion products in the micropores in MAO
coatings would confound the calculation of volume of Mg
alloy and its changes in the initial stage of implantation. As
shown in Fig. 4, it is difficult to conclude which group has a
slower or faster degradation rate by comparing only the
apparent volume of the implanted MgeZr pins, as no
remarkable changes in volume were found within the first 4
weeks of implantation. Thus, it is also appropriate to
compare the densities of implants, as the corroded portion
has lower substrate density than its residual part. As HA is
the dominant ingredient of bone minerals, changes in its
densities were plotted based on reference of HA in Fig. 5.
Both MAO and EPD groups showed a linear decrease in
mineral density of MgeZr pins after its implantation in vivo,
with around 35% reduction in the MAO group as compared to
only 15% reduction in the EPD group, over an implantation
period of 4 weeks (p < 0.01).
Discussion
This comparative study was designed to identify a better
coating method for slowing down the degradation of a Mg-
based alloy developed for potential orthopaedic applica-
tions. Determination of biodegradation or biocorrosion
in vitro and in vivo was an essential methodological
approach for the establishment of guidelines for testing
biocorrosive metals for their potential adaptation in med-
ical applications.
Calculation of corrosion or biodegradation rate
For the calculation of in vitro corrosion rates of Mg or its
alloys, several methods have been proposed, including
quantification of pH values, Mg ion release, hydrogen evo-
lution, mass or volume changes, potentiodynamic polar-
isation, and electrochemical impendence [26]. Apart from
in vitro measurements, choice of media is also a critical
parameter that must be taken into account. phosphate
buffer solution (PBS), hanks balanced salt solution (HBSS),
and simulated body fluid (SBF) solutions are the most
commonly used inorganic media for in vitro tests, as their
inorganic ingredients are similar to those of plasma [27].
However, more and more research revealed that organic
substances in blood should not be ignored, so cell culture
Figure 1 Representative cross-sectional scanning electron microscope images of MgeZr alloys coated with (A) microarc oxidation
or (B) electrophoresis. Layers can be observed clearly (white arrows). Mg Z magnesium; Zr Z zirconium.
44 J. Tang et al.media (e.g., DMEM) with a composition closer to that of the
physiological environment has been recommended widely
[28]. Among the abovementioned methods, pH measure-
ment is the most user-friendly and quickest qualitative
technique for monitoring corrosion behaviour of Mg or its
alloys through the determination of OHe concentration in
extracts. Dissolution of Mg is accompanied by the release
and precipitation of OHe. Thus, the peak value of the pH
curve can reflect corrosion rates of samples in the initial
degradation stage, and the height of the smooth trend
means stable corrosive behaviour. In most of the cases, to
know only the in vitro comparison results of Mg or its alloys
is sufficient; more details on the selected superior alloys
can be obtained through precise and validated quantitative
measurements. Nevertheless, pH values in extracts could
also be a valid prescreening method reflecting cell con-
tacting environments, which would be beneficial for our
better understanding of in vivo biological evaluations
developed for biodegradable Mg-based implants. Our pre-
sent study showed that MgeZr pins coated using EPD had
lower peak pH values and showed a more stable trend thanFigure 2 Changes in pH as a function of immersion time and
an in vitro index of biocorrosion or degradation of the coated
MgeZr alloy pins. Rapid increase in pH was detected in
Dulbecco’s Modified Eagle Medium in which MgeZr alloy pins
underwent (A) microarc oxidation or (B) electrophoresis.
Mg Z magnesium; Zr Z zirconium.samples coated using MAO technique, implying better pro-
tection effects of EPD coating that prevented penetration
of electrolytes. More interestingly, effects of CO2 on the
corrosion behaviour of MgeZr pins was also taken into ac-
count to mimic the real physiological environment due to
the presence of CO2 in our blood ((CO2)eq Z 22e25 mM)
[13]. The gradual decrease of pH values after the attain-
ment of peak values can be ascribed to the dissolution of
CO2 in the media.
Hydrogen gas formation during Mg alloy corrosion
In an in vivo situation, production of hydrogen gas is
accompanied by Mg corrosion (Mg þ 2H2O/ Mg2þ þ 2OHe
þ H2). Basically, 1 mol of hydrogen gas will be produced
with dissolution of 1 mol of Mg. Previous in vivo studies
have shown that hydrogen bubbles are accumulated in local
host tissue if corrosion rates of Mg or Mg alloy implants are
too high. Actually, an increase in local pressure caused by
bubbles affects cell adhesion to implants adversely. As in
the MAO group, bubbles could be observed only around the
implantation site in the initial 2 weeks, our current
comparative study suggested higher in vivo degradation
rates of MgeZr pins coated using MAO in comparison to
those coated by EPD. In the following 2 weeks, bubbles
were not observed around the host tissue in the MAO group,
indicating a slower rate of release of hydrogen from the
implant that was dissolved mainly in the local tissue fluid
and/or entered the blood circulation [29].
Corrosion reflected more sensitively by changes in
Mg alloy mineral density than by changes in its
volume
In our in vivo micro-CT 3D reconstruction of MgeZr im-
plants, both coatings were shown to protect MgeZr pins
efficiently from corrosion in physiological environments, as
their shape and volume remained nearly unchanged during
the 4 weeks. Considering that the deposited products may
confound volume measurement of pins significantly, we
logically proposed to compare their material densities and
found that MAO coating did not protect Mg from corrosion,
Figure 3 Radiographs of distal femora in mice implanted with MgeZr pins coated by (A) microarc oxidation and (B) electro-
phoresis. The broken circles indicate hydrogen bubbles formed during pin degradation. Mg Z magnesium; Zr Z zirconium.
Surface coating of magnesium alloy 45with a 30% decrease in material density as compared with
only 15% reduction in the case of EPD coating in vitro.
Indeed, an electrochemical impendence study of alloys
coated by MAO clearly showed that the layers of substrate
consisted of a porous ceramic coating and an inner barrier
layer [30]. Transmission electron microscopy confirmed an
interconnection among micropores in the outer ceramic
coating [31]. The proposed corrosion mechanism of MAO
coatings on pure Mg or its alloys is illustrated in Fig. 6. With
increasing immersion time, electrolytes would penetrate
into the substrate surface, leading to the formation of
corrosion cracks. At the same time, accumulation of
corrosion products around the implant surface would
facilitate the sealing of holes on MAO coatings both in vitro
and in vivo. Sealing of holes on the coating surface has a
predominant role in reducing degradation of Mg or its alloys
in the initial phase after implantation. In terms of EPD
coating technique, our in vivo radiographic observation
implied that, during implantation, the hydrogen bubblesFigure 4 Representative micro-computed tomography midsagit
coated with (A) microarc oxidation or (B) electrophoresis. Mg Z mwere either not accumulated or absorbed by surrounding
tissues over time, indicating an excellent degradation
resistance by EPD coating, especially attributed to signifi-
cantly fewer number of holes or less surface contact be-
tween tissue fluid and MgeZr pins.
In general, both in vitro and in vivo measurements
proved that EPD coating can protect the substrate better
than MAO coating. The difference in corrosion resistance
may be ascribed to differences in coating structure, which
can be clearly seen from SEM images in Fig. 1, where the
micropores are fully distributed on MAO coatings [19].
However, no cracks or pores can be observed on the surface
of EPD coatings. Although MAO coating can suppress infil-
tration of electrolyte in the short term, during implanta-
tion, interconnected pores will allow penetration of culture
media or body fluid over time. Therefore, controlling pore
size and its number on the coating is one of the key pa-
rameters to be considered while developing an appropriate
MAO coating for surface modification of Mg or its alloys.tal cuts at distal femora of mice implanted with MgeZr pins
agnesium; Zr Z zirconium.
Figure 5 Changes in density of the implanted MgeZr alloy
pins and its hydroxides after implantation of MgeZr alloy into
the distal femora of mice for 4 weeks. Using hydroxyapatite as
the reference, the relative average density of pins was
measured by micro-computed tomography and then processed
with linear fits for quantifying the pin mineral density; the
density decline of MgeZr alloy coated by microarc oxidation
shows a more negative slope (86.03) than that coated by
electrophoresis (29.73). *p < 0.01. Mg Z magnesium; Zr Z
zirconium.
Figure 6 Schematic presentation of the proposed corrosion mech
environment. MAO Z microarc oxidation.
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The current experimental study proposed that EPD coating
provided better anticorrosion ability than MAO coating.
However, findings of the current preclinical study were not
adequate for us to conclude that EPD is a better coating
method and possesses potential for enhancing degradation
resistance of either pure Mg or Mg-based alloys that are used
as biocorrosive internal fixators in clinical applications.
Although poor corrosion resistance of currently available Mg
alloys may be themost challenging issue affecting their wide
orthopaedic applications, other coating-related issues, such
as properties of binding between coatings and substrates,
biocompatibility, long-term biosafety, and wear resistance,
should also be evaluated systemically.
According to previous published works, insufficient
adhesion of coatings is the main obstacle of the EPD tech-
nique and its application despite favourable surface con-
tact and formation of uniform layers. Frequent friction is
known to cause easy peeling off of EPD coatings, especially
in load bearing skeletons, inducing a dramatic increase of
corrosion rates. As a contrast technique, MAO can fabricate
porous coatings with strong adhesion to the substrate, but
tiny pores on coatings are not able to suppress theanisms of MAO-coated pins at different stages of a physiological
• Alteration of electrolyte composition 
• Changes of parameters in coating production
• Combination of multiple coatings
• Further chemical or physical treatments of coatings
In vitro biocompatibility evaluation based on ISO 10993 or newly established ISO standards designed for biodegradable metals 
In vivo biosafety evaluation based on ISO 10993 or newly established ISO standards designed for biodegradable metals 
Fabrication of coatings on Mg based alloys
Bonding Strength Tests
(ASTM D4541 and ISO 4624) Wear Tests(ASTM G65 and G105)
In vitro corrosion rate measurements
(pH, ion release, gas evolution, EIS and PDP)
(ASTM G31 and G102)
Mechanical Tests of coated alloy
(ASTM B557, E290 and E9)
Clinical Trials
Figure 7 Proposed roadmap for clinical translation of pure Mg or Mg alloys with relevant surface coating to meet regulatory
requirements. EIS Z electrochemical impedance; Mg Z magnesium; PDP Z potentiodynamic polarisation.
Surface coating of magnesium alloy 47penetration of media over time during implantation. Either
other potential coatings with stable surface physical prop-
erties or composite coatings would help reduce corrosion
rate. Indeed, Chen and his colleagues [19] used both MAO
and EPD methods in their previous study, and their in vitro
experiments showed that composite coatings have superior
bonding strength and corrosion resistance than single EPD
or MAO coating.
Indeed, micro-CT in vivo can be used to monitor bio-
corrosive behaviour of Mg or its alloys. However, noninva-
sive technology mainly concentrates on mineral structure
(e.g., bone and materials). Actually, both the “remaining”
[i.e., visible two dimensional (2D) or 3D structure] and the
“left” (i.e., released ions) parts of implants should be
tracked carefully. Generally, blood circulation, urinary
excretion, and intestinal output contribute to Mg ion ho-
meostasis in the human body. Therefore, ion concentra-
tions in blood (plasma and erythrocytes), urine, and faeces
should be determined to evaluate health risks of Mg-based
implants, such as hypo- or hypermagnesaemia.
If biomaterial scientists and bioengineers can fabricate
Mg-based alloys with tightly adherent coatings and excel-
lent corrosion resistance, many aspects associated with the
biosafety of coated biocorrosive implants will require our
immediate attention, such as cellecoating material inter-
action, how the local host tissue responds to the coating
materials, and mechanisms of degraded coating materials;
for example, whether the “debris or wear of the coating” is
embedded in the newly formed bone or eliminated via
circulation becomes a safety concern, and further in-
vestigations are highly desirable. Generally, the coatings
prepared either by MAO or by EPD are constituted of several
substances. Firstly, these ingredients of coatings should be
tested in vitro and in vivo to ensure their biological safety
while applying Mg-based medical devices. Secondly, long-
term friction may lead to a production of debris in the
tissue. Thus, the potential risks of debris-induced inflam-
mation should be evaluated carefully based on ISO 10993
standards, which is shown in Fig. 7. In this study, it wasinsufficient to measure in vitro pH values to assess poten-
tial changes of the acidebase microenvironment. In vivo pH
values could be monitored using florescence dyes to eval-
uate the efficiency of coatings in corrosion resistance.
Additionally, osmolality changes in local tissue should be
also assessed carefully, as pH and osmolality are the two
key factors contributing to the biocompatibility of im-
plants. Results of pH and osmolality tests can provide
further details of the biosafety of Mg-based implants with
or without coating.
Although the study of corrosion resistance was the pri-
mary objective in the current study, it should be noted that
an increase in corrosion resistance may apply to all ortho-
paedic indications, as the degradation or corrosion rate is
skeletal site dependent, e.g., weight-bearing versus non-
weight-bearing (stress-dependant), or trabecular bone
versus cortical bone (contact surface dependent, i.e., more
fluid contact in porous trabecular bone and faster corrosion
of Mg alloys as compared with compact cortical bone with
less fluid contact to Mg alloys). In addition, cellematerial
interactions were not considered in the current study to
evaluate potential underlying mechanisms. This study
established a simple in vivo testing model in distal tibial
bone marrow cavity of rabbits without involving mechanical
and skeletal site-specific variations. This implies that or-
thopaedic application is the key variable influencing
corrosion rate of the Mg implants, and in vivo validation and
optimisation of implants made of pure Mg or its alloys shall
serve the standard for relevant applications in the trans-
lational roadmap.Conclusions
In vitro pH measurement of immersion culture media,
in vivo radiographic and micro-CT-based images, as well as
density changes of MgeZr pins indicated that, as compared
with MAO, EPD can produce a better protective coating for
Mg alloys against corrosion. However, more specifically
48 J. Tang et al.designed studies are desirable to understand how the
physiological environment alters corrosion behaviours,
because this is an essential step towards dedicated and
targeted improvement of biocorrosive or biodegradable
medical implants that may meet the orthopaedic applica-
tions with initial mechanical stability for fixation and sub-
sequent degradation towards better healing without
undergoing a removal surgery required for nondegradable
implants or fixators.
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